ProKidney appoints Dr. Bruce Culleton as executive VP of clinical development and commercialization

Dr. Culleton brings over two decades of industry and academic experience in kidney health to ProKidney, a public biotech company that is working to advance its regenerative medicine therapy through multiple clinical trials.

Buckhorn restaurant chain planning new to-go concepts in Downtown Sacramento space

Shea Homes buys 430 acres near Aggie Expressway for 1,000-home community

Rise Investors unveils details, renderings for mixed-use project in East Nashville

Downtown office building sells to local real estate group

ROM Residential sells Koreatown apartment community for $16 million

5 minutes with… Mark Waggoner, general manager of Commonwealth Care Alliance

St. Louis’ and Missouri’s flu rates plummet but we’re not out of the woods yet

Edward Jones edges 2 other locally-based broker-dealers in investor survey

ProKidney appoints Dr. Bruce Culleton as executive VP of clinical development and commercialization

Previous Olive Tree Compounding Pharmacy breaks ground on Rio Rancho location

Next Highmark Health mulls adjusting hybrid work policy

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Johns Hopkins spinout Haystack Oncology to be acquired for up to $450M

Family Business Awards 2022: Scottish Gourmet of Greensboro

Over-the-Rhine Philly cheesesteak restaurant 13th Street Alley closes permanently

Yum Brands exec Allyson Park departs for role as Walmart’s chief communications officer

Mixed-used office and retail building sells in Streeterville

St. Louis Mayor Tishaura Jones signs bills regulating short-term rentals

MENU

FirstStar Group

More Stories

Find out how much cost of living is rising in Milwaukee, other cities